Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$236000.0.

  • Agilon Health's Cash from Financing Activities rose 8321.48% to -$236000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 1194.95%. This contributed to the annual value of -$2.6 million for FY2024, which is 9866.26% up from last year.
  • Latest data reveals that Agilon Health reported Cash from Financing Activities of -$236000.0 as of Q3 2025, which was up 8321.48% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Cash from Financing Activities registered a high of $1.1 billion during Q2 2021, and its lowest value of -$202.0 million during Q2 2023.
  • For the 5-year period, Agilon Health's Cash from Financing Activities averaged around $51.8 million, with its median value being $896000.0 (2021).
  • In the last 5 years, Agilon Health's Cash from Financing Activities surged by 2668813.19% in 2021 and then tumbled by 478872.13% in 2023.
  • Agilon Health's Cash from Financing Activities (Quarter) stood at $10.4 million in 2021, then crashed by 89.15% to $1.1 million in 2022, then tumbled by 174.78% to -$845000.0 in 2023, then surged by 97.4% to -$22000.0 in 2024, then crashed by 972.73% to -$236000.0 in 2025.
  • Its last three reported values are -$236000.0 in Q3 2025, -$2.6 million for Q2 2025, and -$161000.0 during Q1 2025.